Day: August 11, 2022

Portillo’s Inc. Announces Pricing of Public Follow-on Offering of 8,000,000 Shares of Class A Common Stock in “Synthetic Secondary” Transaction

Portillo’s Inc. Announces Pricing of Public Follow-on Offering of 8,000,000 Shares of Class A Common Stock in “Synthetic Secondary” Transaction

CHICAGO, Aug. 11, 2022 (GLOBE NEWSWIRE) — Portillo’s Inc. (“Portillo’s”) (Nasdaq: PTLO), the fast-casual restaurant concept known for its menu of Chicago-style favorites, today announced the pricing of an underwritten public offering of 8,000,000 shares of its Class A common stock at a price to the public of $23.75 per share. The underwriters have a 30-day option to purchase up to an additional 1,200,000 shares of its Class A common stock at the public offering price, less underwriting discounts and commissions. The pre- and post-offering share counts for Portillo’s Class A common stock and Class B common stock are listed below: Pre-Offering Post-Offering (No Option Exercise) Post-Offering (Full Option Exercise) Class A Class B Class A Class B Class A Class B 36,218,355 35,673,321 42,111,955 29,779,721 42,995,996 28,895,680 Total Total Total 71,891,676 71,891,676 71,891,676 The...

Continue reading

Reborn Coffee, Inc. Announces Pricing of Upsized $7.2 Million Initial Public Offering

Reborn Coffee, Inc. Announces Pricing of Upsized $7.2 Million Initial Public Offering

Brea, California, Aug. 11, 2022 (GLOBE NEWSWIRE) — Reborn Coffee, Inc. (Nasdaq: REBN) (“Reborn”, or the “Company”), a California-based retailer of specialty coffee, today announced the pricing of its upsized initial public offering of 1,440,000 shares of its common stock at a public offering price of $5.00 per share, for aggregate gross proceeds of approximately $7.2 million before deducting underwriting discounts, commissions, and other offering expenses. In addition, Reborn has granted the underwriters a 45-day option to purchase up to an additional 216,000 shares of common stock at the public offering price per share, less the underwriting discounts and commissions, to cover over-allotments, if any. The shares are expected to begin trading on the Nasdaq Capital Market on August 12, 2022, under the ticker symbol “REBN” and the...

Continue reading

Bitcoin Well Reports Second Quarter 2022 Results

Bitcoin Well Reports Second Quarter 2022 Results

EDMONTON, Alberta, Aug. 11, 2022 (GLOBE NEWSWIRE) — Bitcoin Well Inc. (the “Company” or “Bitcoin Well”) (TSXV: BTCW), today announced the financial and operating results for the second quarter ended June 30, 2022. The Interim Financial Statements as well as Management’s Discussion and Analysis (“MD&A”) are available on our website and have been filed on SEDAR. Revenues and Gross Profit from our ATMs across Canada and over the counter (“OTC”) in-person offices have remained strong over the last four quarters amidst a volatile market sentiment for cryptocurrencies. Revenue in the second quarter of 2022 increased by 52% and Gross Profit increased by 10% when compared to the first quarter of 2022 mainly due to the diversity of revenue streams we have been focused on growing for the past two years. Going forward in 2022, we are...

Continue reading

Melcor Developments announces second quarter results, declares quarterly dividend of $0.15 per share

Melcor Developments announces second quarter results, declares quarterly dividend of $0.15 per share

EDMONTON, Alberta, Aug. 11, 2022 (GLOBE NEWSWIRE) — Melcor Developments Ltd. (TSX: MRD), an Alberta-based real estate development and asset management company, today reported results for the second quarter and six months ended June 30, 2022. Revenue was down 4% to $104.35 million year-to-date and down 22% in the quarter as a result of the cyclical nature of the real estate industry and timing of sales in the current and comparative periods. Net income was impacted by non-cash fair value gains of $7.81 million on REIT units related to unit price appreciation compared to December 31, 2021 and $3.32 million in fair value losses on investment properties, resulting in net income of $28.38 million or $0.87 per share (basic) year-to-date. This compares with 2021 year-to-date results including non-cash fair value losses of $26.96 million...

Continue reading

Maxim Power Corp. Reports Continued Strong Earnings with $84 million of Revenue and $25 million of Net Income in the First Six Months of 2022

Maxim Power Corp. Reports Continued Strong Earnings with $84 million of Revenue and $25 million of Net Income in the First Six Months of 2022

CALGARY, Alberta, Aug. 11, 2022 (GLOBE NEWSWIRE) — Maxim Power Corp. (“MAXIM” or the “Corporation”) (TSX: MXG) announced today the release of financial and operating results for the second quarter ended June 30, 2022. The unaudited condensed consolidated interim financial statements, accompanying notes and Management’s Discussion and Analysis (“MD&A”) will be available on SEDAR and on MAXIM’s website on August 11, 2022. All figures reported herein are Canadian dollars unless otherwise stated. FINANCIAL HIGHLIGHTS   Three Months Ended June 30, Six Months EndedJune 30, ($ in thousands except per share amounts) 2022 2021 2022 2021 Revenue 48,380 44,342 84,172 74,372 Net income 8,565 29,589 25,463 56,015 Earnings per share – basic 0.17 0.59 0.51 1.12 Earnings per share – diluted 0.15 0.48 0.42 0.91 Adjusted...

Continue reading

Diffusion Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update

Diffusion Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update

•  Aligned with FDA on Design of Phase 2 GBM Trial of TSC; Initiation Expected by End of 2022•  Reported Positive Effects in TSC Altitude Trial•  Ended Quarter with $28.5 million in Cash, Cash Equivalents and Marketable Securities•  Expected Cash Runway into First Quarter of 2024 CHARLOTTESVILLE, Va., Aug. 11, 2022 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company developing novel therapies that may enhance the body’s ability to deliver oxygen to areas where it is needed most, today announced financial results for the quarter ended June 30, 2022, and provided a business update. Development Updates Aligned with FDA on Innovative Trial Design in Glioblastoma Multiforme (“GBM”) Patients: In July 2022, Diffusion announced that it had aligned with the U.S. Food...

Continue reading

Epsilon Reports Second Quarter 2022 Results

Epsilon Reports Second Quarter 2022 Results

HOUSTON, Aug. 11, 2022 (GLOBE NEWSWIRE) — Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today reported second quarter 2022 financial and operating results and material subsequent events following the end of the quarter through the date of this release. Total net revenue interest (NRI) production averaged 27.4 MMcfe/d (Working Interest of 31.4 MMcfe/d) for the three months ended June 30, 2022. Realized natural gas prices of $6.81/Mcf including hedges ($6.88/Mcf excluding hedges) for the three months ended June 30, 2022. Total revenues of $19.9 million ($17.9 million from natural gas, oil, and NGL sales, $2.0 million from gathering and compression fees through our ownership in the Auburn Gas Gathering System) Adjusted EBITDA of $15.6 million for the quarter Net cash provided by operations of $8.1 million and...

Continue reading

ProKidney Corp. Reports Second Quarter 2022 Financial Results and Provides Business Update

ProKidney Corp. Reports Second Quarter 2022 Financial Results and Provides Business Update

Completed business combination with Social Capital Suvretta Holdings, III WINSTON-SALEM, N.C., Aug. 11, 2022 (GLOBE NEWSWIRE) — ProKidney Corp. (formerly Social Capital Suvretta Holdings Corp. III or “SCS”) (Nasdaq: PROK) (the “Company”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced financial results of ProKidney LP (“ProKidney”) and its subsidiaries for the second quarter ended June 30, 2022 and provided an update on recent corporate developments. “During the first half of 2022, we continued to execute on our clinical and operational plan, positioning us well to achieve our near- and longer-term strategic objectives,” said Tim Bertram, Ph.D., Chief Executive Officer of ProKidney. “The funding received through the completion of SCS’ business combination with...

Continue reading

Canacol Energy Ltd. Reports Realized Contractual Natural Gas Sales Volumes of 188 MMscfpd and a 24% Increase in Adjusted EBITDAX to $55.2 million in Q2 2022

Canacol Energy Ltd. Reports Realized Contractual Natural Gas Sales Volumes of 188 MMscfpd and a 24% Increase in Adjusted EBITDAX to $55.2 million in Q2 2022

CALGARY, Alberta, Aug. 11, 2022 (GLOBE NEWSWIRE) — Canacol Energy Ltd. (“Canacol” or the “Corporation”) (TSX:CNE; OTCQX:CNNEF; BVC:CNEC) is pleased to report its financial and operating results for the three and six months ended June 30, 2022. Dollar amounts are expressed in United States dollars, with the exception of Canadian dollar unit prices (“C$”) where indicated and otherwise noted. Highlights for the three and six months ended June 30, 2022 Realized contractual natural gas sales volumes increased 10% and 6% to 188 MMscfpd and 184.9 MMscfpd for the three and six months ended June 30, 2022, compared to 171.5 MMscfpd and 174.5 MMscfpd for the same periods in 2021, respectively. Average natural gas production volumes increased 10% and 6% to 190.6 MMscfpd and 186.9 MMscfpd for the three and six months ended June 30, 2022,...

Continue reading

GCM Mining Announces Second Quarter and First Half 2022 Results

GCM Mining Announces Second Quarter and First Half 2022 Results

TORONTO, Aug. 11, 2022 (GLOBE NEWSWIRE) — GCM Mining Corp. (TSX: GCM; OTCQX: TPRFF) announced today the release of its unaudited interim condensed consolidated financial statements (“Financial Statements”) and accompanying management’s discussion and analysis (MD&A) for the three and six months ended June 30, 2022. All financial figures contained herein are expressed in U.S. dollars (“USD”) unless otherwise noted. Non-GAAP financial performance measures in this press release are identified with “NG”. For a detailed description of each of the non-GAAP measures used in this press release and a detailed reconciliation to the most directly comparable measure under IFRS, please refer to the Company’s MD&A. Second Quarter and First Half 2022 Highlights GCM announced on July 25, 2022 that it will merge with Aris Gold Corporation...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.